Ketoconazole-p-aminobenzoic Acid Cocrystal: Revival of an Old Drug by Crystal Engineering-Reference-Cited by-同舟云学术

Ketoconazole-p-aminobenzoic Acid Cocrystal: Revival of an Old Drug by Crystal Engineering

Published:2020-01-27 Issue:3 Volume:17 Page:919-932
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Martin Flavia¹,Pop Mihaela²^ORCID,Kacso Irina¹,Grosu Ioana Georgeta¹,Miclăuş Maria¹,Vodnar Dan³,Lung Ildiko⁴,Filip Gabriela Adriana⁵,Olteanu Elena Diana⁵,Moldovan Remus⁵,Nagy Andras⁶,Filip Xenia¹^ORCID,Bâldea Ioana⁵

Affiliation:

1. Molecular and Biomolecular Physics Department, National Institute for R&D of Isotopic and Molecular Technologies, 67-103 Donat, 400293 Cluj-Napoca, Romania

2. TeraCrystal, 67-103 Donat, 400293 Cluj-Napoca, Romania

3. Department of Food Science, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Calea Mănăştur 3-5, 400372 Cluj-Napoca, Romania

4. Physics of Nanostructured Systems, National Institute for R&D of Isotopic and Molecular Technologies, 67-103 Donat, 400293 Cluj-Napoca, Romania

5. Department of Physiology, Iuliu Haţieganu University of Medicine and Pharmacy, Clinicilor 1, 400006 Cluj-Napoca, Romania

6. Department of Toxicology, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Calea Mănăştur 3-5, 400372 Cluj-Napoca, Romania

Funder

Autoritatea Nationala pentru Cercetare Stiintifica

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b01178

Reference61 articles.

1. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

2. History of the development of azole derivatives

3. European Medicines Agency. European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-suspension-marketing-authorisations-oral-ketoconazole, 2013.

4. FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems. http://www.fda.gov/Drugs/DrugSafety/ucm362415.htm, 2013.

5. Ketoconazole in Cushing's Disease: Is It Worth a Try?

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphiphilic disodium glycyrrhizin as a co-former for ketoconazole co-amorphous systems: Biopharmaceutical properties and underlying molecular mechanisms;International Journal of Pharmaceutics;2024-11

2. Supramolecular architectures in multicomponent crystals of imidazole-based drugs and trithiocyanuric acid;Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials;2024-07-01

3. Elucidating of Fluconazole Cocrystallization With a Cutting-Edge Nutraceutical Coformer for Enhanced Formulation Strategies;Journal of Pharmaceutical Innovation;2024-06-25

4. Advances in solvent based cocrystallization: Bridging the gap between theory and practice;Journal of Drug Delivery Science and Technology;2024-05

5. Enhancing the Bioavailability of a Novel Enrofloxacin Salt by Inhibiting Precipitation via a Crystallization Inhibitor;Crystal Growth & Design;2024-03-21